These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15499285)

  • 1. [Medical treatment of dysthyroid orbitopathy].
    Badelon I; Morax S
    J Fr Ophtalmol; 2004 Sep; 27(7):822-4. PubMed ID: 15499285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thyroid eye disease.
    Bartalena L; Marcocci C; Tanda L; Pinchera A
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S458-65. PubMed ID: 12192546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications during systemic corticosteroid therapy combined with orbital radiotherapy in patients with graves orbitopathy].
    Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
    Przegl Lek; 2004; 61(8):855-6. PubMed ID: 15789916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University].
    Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
    Przegl Lek; 2004; 61(8):852-4. PubMed ID: 15789915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
    Currò N; Covelli D; Vannucchi G; Campi I; Pirola G; Simonetta S; Dazzi D; Guastella C; Pignataro L; Beck-Peccoz P; Ratiglia R; Salvi M
    Thyroid; 2014 May; 24(5):897-905. PubMed ID: 24417307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy].
    Modelska-Ziółkiewicz A; Gembicki M; Bednarek J; Sowiński J
    Pol Arch Med Wewn; 2003 May; 109(5):469-75. PubMed ID: 14768175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy.
    Bartalena L; Krassas GE; Wiersinga W; Marcocci C; Salvi M; Daumerie C; Bournaud C; Stahl M; Sassi L; Veronesi G; Azzolini C; Boboridis KG; Mourits MP; Soeters MR; Baldeschi L; Nardi M; Currò N; Boschi A; Bernard M; von Arx G;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4454-63. PubMed ID: 23038682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
    Tsujino K; Hirota S; Hagiwara M; Fukada S; Takada Y; Hishikawa Y; Kono M; Abe M
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):857-64. PubMed ID: 11020584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
    Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
    Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
    Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
    Marcocci C; Bartalena L; Panicucci M; Marconcini C; Cartei F; Cavallacci G; Laddaga M; Campobasso G; Baschieri L; Pinchera A
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):33-42. PubMed ID: 3308192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of ophthalmic Graves' disease.
    Leone CR
    Ophthalmology; 1984 Jul; 91(7):770-9. PubMed ID: 6548005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function.
    Ambroziak U; Bluszcz G; Bednarczuk T; Miśkiewicz P
    Endokrynol Pol; 2017; 68(4):430-433. PubMed ID: 28604944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
    Macchia PE; Bagattini M; Lupoli G; Vitale M; Vitale G; Fenzi G
    J Endocrinol Invest; 2001 Mar; 24(3):152-8. PubMed ID: 11314743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.